cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Summit Therapeutics Inc
3 own
7 watching
Current Price
$1.65
$0.1
(6.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
348.3M
52-Week High
52-Week High
5.78
52-Week Low
52-Week Low
0.66
Average Volume
Average Volume
0.8M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization348.3M
icon52-Week High5.78
icon52-Week Low0.66
iconAverage Volume0.8M
iconDividend Yield--
iconP/E Ratio--
What does the Summit Therapeutics Inc do?
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company s lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
Read More
How much money does Summit Therapeutics Inc make?
News & Events about Summit Therapeutics Inc.
Ticker Report
2 months ago
Summit Therapeutics Inc. (NASDAQ:SMMT Get Rating) CEO Mahkam Zanganeh bought 15,973,743 shares of the businesss stock in a transaction that occurred on Wednesday, March 8th. The stock was purchased at an average cost of $1.05 per share, with a total value of $16,772,430.15. Following ...
Business Wire
2 months ago
Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit, we, or the Company) today announced the successful closing of its fully-subscribed $500 million rights offering. The rights offering resulted in the sale of approximately 476.2 million shares of the Companys common stock, par value $0.01, at a price...
Globe Newswire
3 months ago
PHILADELPHIA, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit) on behalf of the Companys shareholders. The investigation seeks to determine whether Summit has issued false and misleading statements and/or failed to ...
Globe Newswire
3 months ago
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit) investors that the firm has initiated an investigation into whether Summit issued ...
Globe Newswire
4 months ago
PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc. (NASDAQ: SMMT) (Summit) on behalf of the Companys investors. The investigation seeks to determine whether Summit issued false and misleading statements and/or failed to ...
Frequently Asked Questions
Frequently Asked Questions
What is Summit Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Summit Therapeutics Inc shares?
plus_minus_icon
How can I buy Summit Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Summit Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Summit Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Summit Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Summit Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Summit Therapeutics Inc?
plus_minus_icon
What percentage is Summit Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Summit Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.65
$0.1
(6.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00